Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 172

1.

Protective properties of rifampin-resistant rough mutants of Brucella melitensis.

Adone R, Ciuchini F, Marianelli C, Tarantino M, Pistoia C, Marcon G, Petrucci P, Francia M, Riccardi G, Pasquali P.

Infect Immun. 2005 Jul;73(7):4198-204.

PMID:
15972510
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4.

Winter AJ, Schurig GG, Boyle SM, Sriranganathan N, Bevins JS, Enright FM, Elzer PH, Kopec JD.

Am J Vet Res. 1996 May;57(5):677-83.

PMID:
8723881
[PubMed - indexed for MEDLINE]
3.

Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.

Vemulapalli R, Contreras A, Sanakkayala N, Sriranganathan N, Boyle SM, Schurig GG.

Vet Microbiol. 2004 Sep 8;102(3-4):237-45.

PMID:
15327798
[PubMed - indexed for MEDLINE]
4.

Vaccination with Brucella abortus rough mutant RB51 protects BALB/c mice against virulent strains of Brucella abortus, Brucella melitensis, and Brucella ovis.

Jiménez de Bagüés MP, Elzer PH, Jones SM, Blasco JM, Enright FM, Schurig GG, Winter AJ.

Infect Immun. 1994 Nov;62(11):4990-6.

PMID:
7927779
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Evaluation of Brucella melitensis B115 as rough-phenotype vaccine against B. melitensis and B. ovis infections.

Adone R, Francia M, Ciuchini F.

Vaccine. 2008 Sep 8;26(38):4913-7. doi: 10.1016/j.vaccine.2008.07.030. Epub 2008 Aug 15.

PMID:
18675869
[PubMed - indexed for MEDLINE]
6.

Antigenic, immunologic and genetic characterization of rough strains B. abortus RB51, B. melitensis B115 and B. melitensis B18.

Adone R, Muscillo M, La Rosa G, Francia M, Tarantino M.

PLoS One. 2011;6(10):e24073. doi: 10.1371/journal.pone.0024073. Epub 2011 Oct 31.

PMID:
22065984
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

In vivo differences in the virulence, pathogenicity, and induced protective immunity of wboA mutants from genetically different parent Brucella spp.

Wang Z, Niu J, Wang S, Lv Y, Wu Q.

Clin Vaccine Immunol. 2013 Feb;20(2):174-80. doi: 10.1128/CVI.00573-12. Epub 2012 Dec 12.

PMID:
23239800
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Protective role of antibodies induced by Brucella melitensis B115 against B. melitensis and Brucella abortus infections in mice.

Adone R, Francia M, Pistoia C, Petrucci P, Pesciaroli M, Pasquali P.

Vaccine. 2012 Jun 8;30(27):3992-5. doi: 10.1016/j.vaccine.2012.04.009. Epub 2012 Apr 20.

PMID:
22521283
[PubMed - indexed for MEDLINE]
9.

Comparison of the efficacy of Brucella abortus strain RB51 and Brucella melitensis Rev. 1 live vaccines against experimental infection with Brucella melitensis in pregnant ewes.

el Idrissi AH, Benkirane A, el Maadoudi M, Bouslikhane M, Berrada J, Zerouali A.

Rev Sci Tech. 2001 Dec;20(3):741-7.

PMID:
11732416
[PubMed - indexed for MEDLINE]
10.

Comparison between immune responses and resistance induced in BALB/c mice vaccinated with RB51 and Rev. 1 vaccines and challenged with Brucella melitensis bv. 3.

Hamdy ME, El-Gibaly SM, Montasser AM.

Vet Microbiol. 2002 Aug 2;88(1):85-94.

PMID:
12119140
[PubMed - indexed for MEDLINE]
11.

B. melitensis rough strain B115 is protective against heterologous Brucella spp. infections.

Adone R, Francia M, Pistoia C, Pesciaroli M, Pasquali P.

Vaccine. 2011 Mar 21;29(14):2523-9. doi: 10.1016/j.vaccine.2011.01.072. Epub 2011 Feb 5.

PMID:
21300102
[PubMed - indexed for MEDLINE]
12.

Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.

Grilló MJ, Manterola L, de Miguel MJ, Muñoz PM, Blasco JM, Moriyón I, López-Goñi I.

Vaccine. 2006 Apr 5;24(15):2910-6. Epub 2006 Jan 6.

PMID:
16439039
[PubMed - indexed for MEDLINE]
13.

Complementation of Brucella abortus RB51 with a functional wboA gene results in O-antigen synthesis and enhanced vaccine efficacy but no change in rough phenotype and attenuation.

Vemulapalli R, He Y, Buccolo LS, Boyle SM, Sriranganathan N, Schurig GG.

Infect Immun. 2000 Jul;68(7):3927-32.

PMID:
10858205
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Characterization of Brucella abortus O-polysaccharide and core lipopolysaccharide mutants and demonstration that a complete core is required for rough vaccines to be efficient against Brucella abortus and Brucella ovis in the mouse model.

Monreal D, Grilló MJ, González D, Marín CM, De Miguel MJ, López-Goñi I, Blasco JM, Cloeckaert A, Moriyón I.

Infect Immun. 2003 Jun;71(6):3261-71.

PMID:
12761107
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis.

Cloeckaert A, Jacques I, Grilló MJ, Marín CM, Grayon M, Blasco JM, Verger JM.

Vaccine. 2004 Jul 29;22(21-22):2827-35.

PMID:
15246618
[PubMed - indexed for MEDLINE]
16.

Rough vaccines in animal brucellosis: structural and genetic basis and present status.

Moriyón I, Grilló MJ, Monreal D, González D, Marín C, López-Goñi I, Mainar-Jaime RC, Moreno E, Blasco JM.

Vet Res. 2004 Jan-Feb;35(1):1-38. Review.

PMID:
15099501
[PubMed - indexed for MEDLINE]
Free Article
17.

Protective live oral brucellosis vaccines stimulate Th1 and th17 cell responses.

Clapp B, Skyberg JA, Yang X, Thornburg T, Walters N, Pascual DW.

Infect Immun. 2011 Oct;79(10):4165-74. doi: 10.1128/IAI.05080-11. Epub 2011 Jul 18.

PMID:
21768283
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Brucellosis vaccines: assessment of Brucella melitensis lipopolysaccharide rough mutants defective in core and O-polysaccharide synthesis and export.

González D, Grilló MJ, De Miguel MJ, Ali T, Arce-Gorvel V, Delrue RM, Conde-Alvarez R, Muñoz P, López-Goñi I, Iriarte M, Marín CM, Weintraub A, Widmalm G, Zygmunt M, Letesson JJ, Gorvel JP, Blasco JM, Moriyón I.

PLoS One. 2008 Jul 23;3(7):e2760. doi: 10.1371/journal.pone.0002760.

PMID:
18648644
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Complement fixation test to assess humoral immunity in cattle and sheep vaccinated with Brucella abortus RB51.

Adone R, Ciuchini F.

Clin Diagn Lab Immunol. 1999 Nov;6(6):787-90.

PMID:
10548564
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Evaluation of protective effect of DNA vaccines encoding the BAB1_0263 and BAB1_0278 open reading frames of Brucella abortus in BALB/c mice.

Sislema-Egas F, Céspedes S, Fernández P, Retamal-Díaz A, Sáez D, Oñate A.

Vaccine. 2012 Nov 26;30(50):7286-91. doi: 10.1016/j.vaccine.2012.09.039. Epub 2012 Sep 28.

PMID:
23026687
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk